- Home
- WVE vs IRS Comparison
WVE vs IRS Comparison
Compare WVE & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- IRS
- Stock Information
- Founded
- WVE 2012
- IRS 1943
- Country
- WVE Singapore
- IRS Argentina
- Employees
- WVE N/A
- IRS N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- IRS Homebuilding
- Sector
- WVE Health Care
- IRS Real Estate
- Exchange
- WVE Nasdaq
- IRS Nasdaq
- Market Cap
- WVE 939.3M
- IRS 1.1B
- IPO Year
- WVE 2015
- IRS 1994
- Fundamental
- Price
- WVE $6.35
- IRS $15.23
- Analyst Decision
- WVE Strong Buy
- IRS Strong Buy
- Analyst Count
- WVE 11
- IRS 1
- Target Price
- WVE $20.91
- IRS $12.62
- AVG Volume (30 Days)
- WVE 1.7M
- IRS 131.6K
- Earning Date
- WVE 05-08-2025
- IRS 05-06-2025
- Dividend Yield
- WVE N/A
- IRS 10.81%
- EPS Growth
- WVE N/A
- IRS N/A
- EPS
- WVE N/A
- IRS N/A
- Revenue
- WVE $104,939,000.00
- IRS $325,094,048.00
- Revenue This Year
- WVE N/A
- IRS N/A
- Revenue Next Year
- WVE N/A
- IRS N/A
- P/E Ratio
- WVE N/A
- IRS N/A
- Revenue Growth
- WVE N/A
- IRS N/A
- 52 Week Low
- WVE $4.25
- IRS $8.21
- 52 Week High
- WVE $16.74
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- WVE 40.37
- IRS 62.91
- Support Level
- WVE $5.62
- IRS $13.51
- Resistance Level
- WVE $7.07
- IRS $15.69
- Average True Range (ATR)
- WVE 0.60
- IRS 0.65
- MACD
- WVE 0.01
- IRS 0.13
- Stochastic Oscillator
- WVE 26.35
- IRS 78.90
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.